The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template

Nucleic Acids Research

Volumn 38, Issue 18, 2010, Pages 6018-6028

  Coustry, Françoise ^a,b   Oh, Chun do ^a   Hattori, Takako ^a,c   Maity, Sankar N ^a   de Crombrugghe, Benoit ^a   Yasuda, Hideyo ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; DNA; TRANSCRIPTION FACTOR SOX9; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL LINE; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; DNA PROTEIN COMPLEX; DNA TEMPLATE; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; TRANSCRIPTION INITIATION; WILD TYPE; ANIMAL; CHEMISTRY; ENHANCER REGION; GENETICS; METABOLISM; MUTATION; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CELL LINE; CHONDROCYTES; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLLAGEN TYPE II; DIMERIZATION; DNA; ENHANCER ELEMENTS, GENETIC; HUMANS; MUTATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 78049419970     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq417     Document Type: Article

References (29)

1. Johnson,R.L. and Tabin,C.J. (1997) Molecular models for vertebrate limb development. Cell, 90, 979-990.
2. de Crombrugghe,B., Lefebvre,V. and Nakashima,K. (2001) Regulatory mechanisms in the pathways of cartilage and bone formation. Curr. Opin. Cell Biol., 13, 721-727.
3. Lefebvre,V. and Smits,P. (2005) Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res. C Embryo Today, 75, 200-212.
4. Foster,J.W., Dominguez-Steglich,M.A., Guioli,S., Kowk,G., Weller,P.A., Stevanovic,M., Weissenbach,J., Mansour,S., Young,I.D., Goodfellow,P.N. et al. (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature, 372, 525-530.
5. Wagner,T., Wirth,J., Meyer,J., Zabel,B., Held,M., Zimmer,J., Pasantes,J., Bricarelli,F.D., Keutel,J., Hustert,E. et al. (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell, 79, 1111-1120.
6. Stolt,C.C., Lommes,P., Sock,E., Chaboissier,M.C., Schedl,A. and Wegner,M. (2003) The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev., 17, 1677-1689.
7. Vidal,V.P., Chaboissier,M.C., Lützkendorf,S., Cotsarelis,G., Mill,P., Hui,C.C., Ortonne,N., Ortonne,J.P. and Schedl,A. (2005) Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr. Biol., 15, 1340-1351.
8. Mori-Akiyama,Y., van den Born,M., van Es,J.H., Hamilton,S.R., Adams,H.P., Zhang,J., Clevers,H. and de Crombrugghe,B. (2007) SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology, 133, 539-546.
9. Bi,W., Huang, W., Whitworth, D.J., Deng,J.M., Zhang,Z., Behringer,R.R. and de Crombrugghe,B. (2001) Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl Acad. Sci. USA, 98, 6698-6703.
10. Bi,W., Deng,J.M., Zhang,Z., Behringer,R.R. and de Crombrugghe,B. (1999) Sox9 is required for cartilage formation. Nat. Genet., 22, 85-89.
11. Akiyama,H., Chaboissier,M.C., Martin,J.F., Schedl,A. and de Crombrugghe,B. (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev., 16, 2813-2828.
12. Lefebvre,V., Huang,W., Harley,V.R., Goodfellow,P.N. and de Crombrugghe,B. (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell. Biol., 17, 2336-2346.
13. Zhou,G., Lefebvre,V., Zhang,Z., Eberspaecher,H. and de Crombrugghe,B. (1998) Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J. Biol. Chem., 273, 14989-14997.
14. Bell,D.M., Leung,K.K., Wheatley,S.C., Ng,L.J., Zhou,S., Ling,K.W., Sham,M.H., Koopman,P., Tam,P.P. and Cheah,K.S. (1997) SOX9 directly regulates the type-II collagen gene. Nat. Genet., 16, 174-178.
15. Ng,L.J., Wheatley,S., Muscat,G.E., Conway-Campbell,J., Bowles,J., Wright,E., Bell,D.M., Tam,P.P., Cheah,K.S. and Koopman,P. (1997) SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol., 183, 108-121.
16. Genzer,M.A. and Bridgewater,L.C. (2007) A Col9a1 enhancer element activated by two interdependent SOX9 dimers. Nucleic Acids Res., 35, 1178-1186.
17. Zhang,P., Jimenez,S.A. and Stokes,D.G. (2003) Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. J. Biol. Chem., 278, 117-123.
18. Bridgewater,L.C., Walker,M.D., Miller,G.C., Ellison,T.A., Holsinger,L.D., Potter,J.L., Jackson,T.L., Chen,R.K., Winkel,V.L., Zhang,Z. et al. (2003) Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res., 31, 1541-1553.
19. Xie,W.F., Zhang,X., Sakano,S., Lefebvre,V. and Sandell,L.J. (1999) Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J. Bone Miner. Res., 14, 757-763.
20. Sekiya,I., Tsuji,K., Koopman,P., Watanabe,H., Yamada,Y., Shinomiya,K., Nifuji,A. and Noda,M. (2000) SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem., 275, 10738-10744.
21. Rentsendorj,O., Nagy,A., Sinko,I., Daraba,A., Barta,E. and Kiss,I. (2005) Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissueand developmental stage-specific activity of the matrilin-1 gene. Biochem. J., 389, 705-716.
22. Jenkins,E., Moss,J.B., Pace,J.M. and Bridgewater,L.C. (2005) The new collagen gene COL27A1 contains SOX9-responsive enhancer elements. Matrix Biol., 24, 177-184.
23. Sock,E., Pagon,R.A., Keymolen,K., Lissens,W., Wegner,M. and Scherer,G. (2003) Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia. Hum. Mol. Genet., 12, 1439-1447.
24. Bernard,P., Tang,P., Liu,S., Dewing,P., Harley,V.R. and Vilain,E. (2003) Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum. Mol. Genet., 12, 1755-1765.
25. Coustry,F., Hu,Q., de Crombrugghe,B. and Maity,S.N. (2001) CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure. J. Biol. Chem., 276, 40621-40630.
26. Dignam,J.D., Lebovitz,R.M. and Roeder,R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
27. Kamakaka,R.T., Bulger,M. and Kadonaga,J.T. (1993) Potentiation of RNA polymerase II transcription by Gal4-VP16 during but not after DNA replication and chromatin assembly. Genes Dev., 7, 1779-1795.
28. Kamakaka,R.T. and Kadonaga,J.T. (1994) The soluble nuclear fraction, a highly efficient transcription extract from Drosophila embryos. Methods Cell. Biol., 44, 225-235.
29. Peirano,R.I. and Wegner,M. (2000) The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res., 28, 3047-3055.